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Abstract.
Engineering articular cartilage substitutes using hydrogels
with encapsulated cells is an approach that has received
increasing attention in recent years. Hydrogels based on
κ-carrageenan (κC), a thermoreversible natural-origin polymer,
have been recently proposed as new cell/growth factor
delivery vehicles for regenerative medicine. In this work, we
report the potential of such hydrogels encapsulating either
human-adipose-derived stem cells (hASCs), human nasal
chondrocytes (hNCs), or a chondrocytic cell line (ATDC5) for
cartilage regeneration strategies. The in vitro cellular behavior
of the encapsulated cells within κC hydrogel was analyzed
after different culturing periods using biochemical assays and
histological and real-time reverse-transcription PCR analysis.
The three types of cells encapsulated in κC hydrogels showed
good cellular viability and proliferation up to 21 days of
culture, and the cell-laden hydrogels were positive for speciﬁc
cartilage markers. In summary, the results demonstrate that
hASCs embedded in κC hydrogels proliferate faster and exhibit
higher expression levels of typical cartilage markers as
compared with hNCs or ATDC5 cells. Based on these data, it is
possible to conclude that κC hydrogel provides a good support
for culture and differentiation of encapsulated cells and that
hASCs may provide an advantageous alternative to primary
chondrocytes, currently used in clinical treatments of cartilage
defects/diseases.
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1. Introduction
The limited capacity of adult articular cartilage for self-repair is
well recognized and is explained by its being an avascular and
aneural tissue that consistsof relatively fewcells that cannotmi-
grate; speciﬁcally,mesenchymal stemcells cannot recruit or get
easy access to damaged areas [1],[2]. Currently, clinically used
therapies involve either surgical technique or autologous chon-
drocyte transplantation,which are generally successful in terms
of pain relief and improved function but do not completely re-
store the articular cartilage function [3]. Although the use of au-
tologous chondrocytes has the advantages of avoiding possible
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chondrocytes; MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
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immune rejection or disease transmission, their wider applica-
tion presents several limitations associated with the harvesting
and in vitro proliferation procedures. The isolation of autolo-
gous chondrocytes requires an additional surgical intervention
to harvest cartilage tissue, which often results in donor-site
morbidity. Moreover, the amount of articular cartilage tissue is
limited, even if retrieved from a different site location such as
the nasal septum [4]. In addition, the in vitro chondrocyte pro-
liferation must be narrowed because these cells easily dediffer-
entiate in monolayer cultures and because of their low capacity
to produce stable cartilage upon in vivo implantationwith a ten-
dency to form ﬁbrous cartilage [5]. Because adult stem cells can
be isolated from various tissue sources and have the ability to
proliferate and differentiate along multiple lineage pathways in
a reproduciblemanner, they have received great attention as an
alternative resource to autologous chondrocytes, overcoming
the limited number of primary chondrocytes and proliferation
capacity [6],[7]. Thus, many studies have been conducted to
evaluate the use of adult stem cells in cartilage tissue engineer-
ing, most of them focusing on the use of bone marrow stem
cells. Recently, adipose-derived stem cells (ASCs) have been
regarded as good candidates for the repair and regeneration
of articular hyaline cartilage because of their availability, long-
term cell viability, and multilineage differentiation potential,
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including differentiation into the chondrogenic phenotype [8].
In fact, estimated yields of stem cells are in the range of 400,000
stem cells per milliliter of adipose tissue [9], resulting in up to
a 300-fold increase in cell number from 100 g of adipose tissue
as compared with 100 mL of bone marrow aspirate [10]. Never-
theless, in approaches consisting of the direct implantation of
cells into the injured cartilage area, there are some challenging
issues such as leakage of transplanted cells from the cartilage
defects, leading to low cell retention and donor site morbidity
[11]. Thus, three-dimensional (3D) vehicles such as hydrogels
have been proposed to deliver high amounts of cells with a
well-maintained phenotype to facilitate cell retention and assist
in mechanical stability of the transplantation site [12]. In addi-
tion, the use of hydrogels might provide important features for
cell functionality becauseof their high tissue-likewater content,
closelymimicking thenatural environment in thebody, enabling
efﬁcient transport of nutrients andwaste [13], and thepossibility
to control the release pattern of signaling molecules by incor-
porating them into the hydrogel by physical and/or chemical
means. Various studies have demonstrated the successful use
of natural polymeric hydrogels for cell encapsulation and in
vitro culture purposes such as hyaluronic acid [14], agarose
[15], collagen, alginate [16],[17], and chitosan [18]. However,
their mechanical properties are often insufﬁcient for the sta-
bility of the tissue-like construct transplantation. Furthermore,
hyaluronic acid promotes early inﬂammation, which is then
rapidly metabolized in vivo by free radicals and hyaluronidase
[19]. Alginatehashighmolecularweight and therefore cannot be
readily eliminated by the body [20], and chitosan induce rapid
bone regeneration at initial stages [21]. κ-Carrageenan (κC), an
ionic hydrogel proposed recently for cartilage regeneration ap-
proaches, which forms a gel with potassium ions but also shows
gelation under salt-free conditions, has demonstrated advanta-
geous properties compared with other systems currently pro-
posed for cartilage tissue repair. In this study, we evaluated the
ability of κC hydrogels to support cellular functionalities, com-
paring simultaneously the potential of using human-adipose-
derived stem cells (hASCs) versus primary human chondro-
cytes, in cartilage regeneration strategies. Additionally, ATDC5,
a murine, well-characterized chondrogenic cell line, routinely
used as a model system to study the chondrogenic process,
was used as a control. The three different cell types were en-
capsulated in κC hydrogels and cultured for up to 21 days.
The cells’ response was evaluated in terms of metabolic activ-
ity (3-[4,5-dimethylthiazol-2-yl]-5-[3-carboxymethoxyphenyl]-
2-[4-sulfophenyl]-2H-tetrazolium [MTS] assay), proliferation
(DNA), presence of glycosaminoglycans (GAGs; typical histo-
logical staining—Alcian blue and Safranin O), and by the ex-
pression of speciﬁc cartilage markers (namely, Sox9, aggre-
can, collagen type I, COL2, and collagen type X) using real-time
quantitative reverse-transcription PCR (qRT-PCR) analysis. The
results obtained suggest that κC hydrogel enables beneﬁcial
cellular response supporting extracellular formation and sus-
taining the chondrogenic phenotype. Moreover, encapsulated
hASCs exhibit the highest proliferation rates and highest lev-
els of chondrogenic marker expression, encouraging the use of
these cells and the κC hydrogels as cell delivery carriers for
applications in the regeneration of articular cartilage defects.
2. Experimental
2.1. Materials
κ-Carrageenan powder (22048), potassium chloride (KCl,
P5405), phosphate buffered saline (PBS) tablets (P4417), Dul-
becco’s PBS (D5652), Dulbecco’s modiﬁed Eagle’s Medium
(DMEM)—low glucose (D5523), sodium bicarbonate (NAHCO3,
S5761), and dexamethasone (D8893) were purchased from
Sigma–Aldrich (Munich, Germany). Fetal bovine serum (FBS,
10270-106) and antibiotic–antimycotic (A/B, 15240-062) were
purchased from Invitrogen (Karlsruhe, Germany). MTS reagent
was purchased from Promega (Southampton, UK).
2.2. κC hydrogel preparation
An aqueous solution was prepared by dissolving the κC powder
(herein referred as κC) in distilled water and heating at 60◦C
while stirring constantly from 30 Min until complete and ho-
mogeneous dispersion of the material was observed. The 1.5%
(w/v)hydrogel solutionwassterilizedbysteampower for30Min
at 120◦C. The samples were produced in the form of discs using
cylindermoulds, and a complete gelationwas achievedwith KCl
immersion for 10–15Min at room temperature to stabilize the 3D
structure. Afterward, the gels were washed with PBS to remove
the excess of ions. Water content, degradation rate, and cell
culture experiments were all performed using hydrogel discs
with Ø 5 ± 0.01 × 2.5 ± 0.46 mm2 height.
2.3. Cell isolation and expansion
Human-adipose-derived stem cells were obtained from liposuc-
tion procedures, under protocols established with the Plastic
Surgery Department, Hospital da Prelada (Porto, Portugal), and
isolated by enzymatic digestion, as previously described [22].
Brieﬂy, the adipose tissue samples were digested with 0.2%
collagenase type II (C6885; Sigma–Aldrich) in PBS for 45 Min
at 37◦C under gentle stirring. The digested tissue was ﬁltered
with a 100-μm ﬁlter mesh (Sigma–Aldrich) centrifuged at 290g
for 10Min at 20◦C, and the cell suspension solutionwaswashed
5 Min with lysis buffer to remove the erythrocytes. The ad-
herent hASCs were expanded in minimum essential medium
(MEM) alphamedium (12000-063; Invitrogen, Grand Island, NY,
USA) with 10% (v/v) FBS, 1% A/B, and sodium bicarbonate with
media changes every 3 days. Nasal cartilage was harvested
from the nasal septum of adult patients undergoing reconstruc-
tive surgery under a protocol established with Hospital de Sa˜o
Marcos (Braga, Portugal). The chondrocyte isolation procedure
followed a protocol presented elsewhere [23]. Brieﬂy, the hu-
man nasal septum cartilage tissue was cut into pieces, washed
in sterile PBS solution, and incubated in 20 mL of trypsin–
ethylenediaminetetraacetic acid (DMEM) solution for 30 Min
at 37◦C on agitation. Then, trypsin was removed and 20 mL
of ﬁlter-sterilized collagenase type II solution (2 mg/mL) in
basic medium was added, and the mixture was incubated for
12 H. The digested tissue and cell suspension solution was cen-
trifuged at 200g for 7 Min and the supernatant was removed.
The cell pellet was washed with lysis buffer, centrifuged sev-
eral times, and ﬁnally resuspended in expansion medium con-
sisting of DMEM—high glucose (5671; Sigma, St. Louis, MO,
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USA), containing 10mMHEPESbuffer (H403475, pH7.4;Sigma),
1% A/B, 20 mM l-alanyl glutamine (G8541; Sigma), 1× MEM
nonessential amino acids (11140-035; Sigma), and 10% (v/v)
FBS supplemented with 10 ng/mL basic ﬁbroblast growth factor
(AF100-18B; PeproTech, London, UK). ATDC5 (cell line mouse
129 teratocarcinoma AT805 derived, ECACC, Porton Down, Wilt-
shire,UK) cellswereexpanded inHam’sF-12cell culturemedium
(D-MEM/F-12 [1:1], 42400-028; Gibco, UK) supplemented with
10% FBS, 2 mM l-glutamine (G854; Sigma), and 1% antibiotic
solution until obtaining the necessary number of cells for the
experiments.
2.4. Hydrogel characterization
2.4.1. Water content and degradation rate
Hydrogel samples (111.15 ± 12.66 mg) prepared according to
the procedure described above and accurately weighed (ws)
were incubated for7, 14,and21days in freshculturemediumand
PBS buffer. Simultaneously, samples of hydrogels loaded with
hASCs,humannasal chondrocytes (hNCs), andATDC5 (prepared
as described in the section below) were immersed in speciﬁc
culture medium for each type of cell and incubated at 37◦C for
the same time periods. At predetermined time intervals, the
medium/PBS was removed from the samples, the hydrogels
were lyophilized, and dry weights were measured (wd). The
water content of hydrogels was calculated from the equation
(ws − wd)/ws × 100. The degradation rate was deﬁned as the
time needed for the gel to degrade, and for calculation, we
considered Eq. (1). The medium was replaced twice a week and
the studies were performed in triplicate.
Degradation rate (%) = Final weight
Initial weight
× 100 (1)
2.4.2. Cell encapsulation into κC hydrogels
The κC hydrogels were produced using the ionotropic gelation
method described above, and cells—namely, ATDC5, hNCs, and
hASCs—were encapsulated at a density of 5 × 106 cells/mL
and cultured for 7, 14, and 21 days. The mixture composed
of the κC aqueous solution, and the cell suspension was re-
suspended until complete homogenization. Hydrogel samples
loaded with different cell types were prepared using sterile
polystyrene cylinder moulds. Discs with encapsulated hASCs
were cultured in chondrogenic differentiation medium com-
posed of DMEM—low glucose (D5523-DMEM; Sigma), supple-
mented with 1% A/B, ITS + 1 liquid media supplement (I2521-
insulin–transferrin–selenium; Sigma), 17 mM l-ascorbic acid
(A4544; Sigma), 0.1 M sodium pyruvate (P4562; Sigma), 35 mM
l-proline (P5607; Sigma), 1 mM dexamethasone, and 10 ng/mL
ofhumantransforminggrowth factor-β1 (TGF-β1, 14-8348;eBio-
science, Ireland, UK). Encapsulated hNCs and ATDC5 were cul-
tured in the previously mentioned culture mediums. Additional
controls consisted of κC hydrogel samples without cells, kept
in the same culturing conditions for the selected time periods.
At the end of each time of culture, the samples were retrieved,
washed with PBS solution, and further processed according
to the characterization assays to be performed, as described
below.
3. Biological evaluation
3.1. Cell morphology and viability [calcein
acetoxymethyl ester (AM) assay]
The morphology of the different cells before encapsulation was
examined using an inverted light microscope (Axiovert 40 CFL,
459306; Zeiss, Jena, Germany), and imageswere obtainedusing
a digital photo camera (PowerShot G6; Canon, Tokyo, Japan).
The viability of the cells encapsulated in the κC hydrogel along
the culture period was assessed using the Calcein AM assay.
For this purpose, Calcein AMdye (C3099; Invitrogen) solution of
1/1,000 was prepared in the culture medium. At the end of each
time point of the study, the κC hydrogel samples with encap-
sulated cells were collected from the culturing plates and incu-
bated in the calcein AM solution for 15–30Min at 37◦C and after-
wards washed in sterile PBS. The stained samples were placed
on amicroscope slide and observed under a ﬂuorescencemicro-
scope with a 485 ± 10 nm optical ﬁlter (reﬂected/transmitted
light microscope; Zeiss).
3.2. Metabolic activity: MTS assay
The metabolic activity of hASCs, hNCs, and ATDC5 cells en-
capsulated in κC hydrogel and cultured for the predetermined
time points was assessed using the CellTiter 96 R© AQueous
One Solution Cell Proliferation Assay kit (MTS; Promega, Madi-
son, WI, USA), which is based on bioreduction of the substrate
into a brown formazan product by dehydrogenase enzymes in
metabolically active cells and is commonly used for cell viabil-
ity evaluation. Brieﬂy, cell–hydrogel constructs (n = 9) were
washed in PBS and placed in a mixture containing serum-
free cell culture medium DMEM (without phenol red) and MTS
reagent in a 5:1 ratio and incubated for 3 H at 37◦C in a humidi-
ﬁed atmosphere containing 5% CO2, at the end of which 100 μL
was transferred to 96-well plates and the optical density was
determined at 490 nm.
3.3. Cell proliferation: DNA quantiﬁcation
The proliferation of the encapsulated cells in the κC hydrogels
was assessed using a ﬂuorimetric double-strand DNA (dsDNA)
quantiﬁcation kit (P7589-PicoGreen, Molecular Probes; Invit-
rogen, Paisley, UK). For this purpose, samples collected on 0,
7, 14, and 21 days of culturing were properly washed in PBS
and then transferred into 1.5-mL microtubes containing 1 mL
of ultrapure water. Prior to dsDNA quantiﬁcation, cell–hydrogel
constructs and the sample controls (hydrogel samples without
cells) were thawed and sonicated for 15 Min. Samples and stan-
dards (ranging from 0 to 2 μg/mL) were prepared and mixed
with a PicoGreen solution (Invitrogen) in a 200:1 ratio and were
added to a 96-well opaque white plate. Each sample or stan-
dard was made in triplicate. The procedure followed can be
found elsewhere [24] and was based on manufacture instruc-
tions. The plate was incubated for 10 Min in the dark, and ﬂu-
orescence was measured on a microplate reader (Synergy HT;
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BioTek,Winooski, VT, USA) with an excitation of 485/20 nmand
an emission of 528/20 nm. A standard curve was created, and
sample DNA values were read from the standard graph.
3.4. Typical proteoglycans staining—Alcian blue
and Safranin O
Alcian blue and Safranin O staining were used to evaluate
cartilage extracellular matrix component deposition—namely,
GAGs—on samples that were collected at the end of the exper-
iment (21 days of culture). Alcian blue (A3157; Sigma) staining
was performed by incubating the monolayer cells or the cell-
laden hydrogels for 30 Min. After that, the stain was poured off
and the samples were washed and dehydrated. The Safranin
O staining consisted of staining the cells with Weigert’s iron
hematoxylin working solution for 7 Min and 0.1% Safranin O for
5 Min. Samples were washed after each staining step, left to
air dry, and then rinsed in absolute alcohol. Stained cells were
observed under a light microscope (reﬂected/transmitted light
microscope; Zeiss), and images were captured using a camera
(Axion MRc5; Zeiss).
3.5. RNA isolation and real-time qRT-PCR analysis of
chondrogenic markers
The messenger RNA (mRNA) expression of chondrogenic genes
(Sox9, aggrecan, collagen type I, COL2, and collagen X) by
the different cell types studied encapsulated in κC hydrogels
was quantiﬁed by real-time qRT-PCR analysis. Total RNA was
extracted using TRI Reagent R© RNA isolation reagent (T9424;
Sigma) following the manufacturer’s instructions. First-strand
complementary DNA (cDNA) was synthesized from 2 μg of
RNA of each sample reverse transcribed with qScriptTM cDNA
Synthesis Kit (Quanta Biosciences, Gaithersburg, MD, USA) in
a 40 μL reaction using a MJ MiniTM Personal Thermal Cycler
(Bio-Rad Laboratories, Berkeley, CA, USA) machine. Real-time
qRT-PCR was performed to detect ampliﬁcation variations us-
ing PerfeCTa R© SYBR R© Green FastMix R©, (Quanta Biosciences)
on Eppendorf Mastercycler R© ep realplex gradient S machine
according to manufacturer’s instructions in a 20 μL reaction
containing 2.5 μL of each primer. The relative quantiﬁcation of
the gene expression was calculated using the 2−Ct and 2−Ct
method [25]. The mRNA expression levels of target genes were
normalized to the average expression of endogenous house-
keeping gene GAPDH (glyceraldehyde-3-phosphate dehydro-
genase) value. Each quantitative real-time PCR run was carried
out with an initial incubation at 95◦C for 2 Min, followed by 45
cycles of denaturation (95◦C, 30 Sec), corresponding annealing
temperature for 30 Sec and extension step at 72◦C for 30 Sec.
A melting curve of 21 Min and a hold step at 5◦C was performed
at the end.
3.6. Statistical analysis
Sets of triplicates were expressed in mean ± SD for water
contentanddegradation rate (n=3),MTS,DNA(n=9), andqRT-
PCRdata (n=3). First, a Shapiro–Wilk testwasused to ascertain
the data normality. The results indicated that at the 0.05 level,
the data were signiﬁcantly drawn from a normally distributed
population, and one-way analysis of variance (ANOVA) followed
by Tukey’s test was used to determine signiﬁcant differences
between groups and conditions. The difference was considered
signiﬁcant when P < 0.05 [26].
4. Results and discussion
Tissue engineering is an emerging approach for the regenera-
tion of damaged cartilage tissue due to disease or trauma [27]
and because cartilage lacks self-regenerative ability, it is essen-
tial to develop methodologies for delivery of clinically relevant
number of cells and/or cytokines and growth factors to the de-
fect site. It is well known that in many situations, cells alone are
not able to efﬁciently initiate a regeneration process once im-
planted, due to the dispersion or immune system rejection. Cell
encapsulation techniques through hydrogel systems confer the
means toovercomesomeof theseproblems [28]. Themotivation
of using a κC hydrogel as a cell support was to take advantage
of its intrinsic properties and composition, being a hydrophilic
polysaccharide with high swelling properties, characterized by
its sulfate group’s content, similar to GAG constituents. Addi-
tionally, it is a thermoreversible and an ionic gel with the ability
to form hydrogels at conditions that allow in situ gelation and
direct encapsulation of cells. These hydrogels have been in-
vestigated as drug delivery or growth factor delivery systems
[29–31] for immobilization of enzymes [32], but have been very
little explored until the present time for cartilage restoration
[33]. In this study, we aimed at analyzing the behavior of κC
hydrogels as encapsulation systems for adipose stem cells and
primary chondrocytes.
4.1. Water content and degradation rate
In addition to the increase in the mass of the hydrogels, high
water content ability may inﬂuence the biological behavior of
the cells. The matrix environment, in which cells are grown,
inﬂuences the type and extent of cellular response, which in
turn affects cell viability and proliferation. Therefore, the wa-
ter content/degradation rate of the developed hydrogels was
evaluated in simulated physiological conditions, as the diffu-
sion, exchange of nutrients, and waste throughout the entire
hydrogel are related to the level of water being substituted with
the surrounding medium. κC has an abundant number of hy-
drophilic groups, such as sulfate groups, which can promote
a high water uptake in the structure. No previous dehydration
of the hydrogels was performed, envisioning a better simula-
tion of their application at the in vivo scenario. Signiﬁcantly
higher water content was observed for the hydrogels immersed
in PBS as compared with the hydrogels dipped in DMEM/10%
FBS (Fig. 1A) after 21 days, possibly due to the ionic compo-
sition of the solutions. Previous research studies have shown
that the swelling behavior of hydrogels depends on the exter-
nal environment such as ionic strength, temperature, and pH
[34]. The high water content of the hydrogels immersed in PBS
could relate to the higher exchange between the ions from the
medium and the potassium ions needed for the cross-linking of
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Fig. 1. (A) Water content and (B) degradation rate of κC hydrogels as a function of time, registered after immersion in
DMEM/10%FBS and in PBS solution at 37◦C and pH 7.4. (C) Water content and (D) degradation rate of κC hydrogels with
encapsulated cells (hASCs, hNCs, and ATDC5) versus immersion time in culture medium (speciﬁc for each type of cell). Values
reported as averages (n = 3) ± SD.
κC hydrogel. Thus, the lower water content registered for the
hydrogels exposed to DMEM/10%FBS can be explained by the
lower ionic exchange,butalsodue topossiblebindingof theFBS
proteins present in the culturemedium to the κC hydrogel sites.
Nevertheless, all the hydrogel samples exhibited water content
superior to 98% either in DMEM/10% FBS or in PBS medium.
The degradation experiments were performed at neutral pH,
resembling physiological conditions, (Fig. 1B) and, in general,
the results show a higher decrease in dry mass for hydrogels in
PBS as compared with hydrogels incubated in DMEM/10% FBS,
in agreement with the water uptake results. Water content and
degradation of the hydrogels with encapsulated cells were also
evaluated after culturing for 7, 14, and 21 days at 37◦C (Figs. 1C
and 1D). The highest water uptake was registered for κC laden
with ATDC5 cells, followed by hydrogels loaded with hNCs and
hASCs. The mass-loss difference found between the different
cell types could be associated with the particular stage of their
growth cycle at each time point analyzed. For hASCs, this be-
havior could be linked to a higher extracellular matrix formation
because the stem cells undergo differentiation stimulated by
the culturingmedia. In fact, cell encapsulation and extracellular
matrix depositionmay result in progressive increase in themass
or in the mechanical properties for the hydrogels, as shown be-
fore for other systems [35]. In this study, this was corroborated
with the qRT-PCR data (see below), aswe observe an increase in
the aggrecan and collagen gene expression for hASCs and hNCs
[demonstrating higher extracellular matrix (ECM) deposition]
and the lowest expression for ATDC5 cells.
4.2. Cell morphology and distribution
Adult stem cells have recently received great attention as an
alternative resource to overcome the limited supply, as well as
the dedifferentiation process often observed in primary chon-
drocytes in vitro expanded in monolayer. The use of cell lines
in cell-based therapies is not considered safe, as these cells
are often derived from tumors and typically accumulate genetic
changeswith increasingpassage levels [36]. Opticalmicroscopy
was used to analyze hASCs, hNCs, and ATDC5 cell morphology
in monolayer after 7 days in culture (Fig. 2A). Images depict
the morphology of the different cell types—hASCs and hNCs
presenting a ﬁbroblast-like appearance due to chondrogenic
phenotype instability, and ATDC5 cells exhibiting an extended,
polygonal shape [37]. Inmonolayer culture, ATDC5 cells seemed
to achieve conﬂuence faster than hASCs and hNCs. Once differ-
ent cells were encapsulated in the same hydrogel, the cell be-
haviorwas expected to be different, independently of additional
inﬂuence of the hydrogel matrix. Fluorescence microscopy im-
ages of the cell-laden hydrogels are presented in Fig. 2B. The
viability of encapsulated cells within the polysaccharide hydro-
gel was conﬁrmed by the positive cell staining with calcein AM.
The ﬂuorescence images also show homogeneous distribution
136 Biotechnology and Applied Biochemistry
Fig. 2. (A) Micrograph images obtained from 2D-cultured
cell monolayer of hASCs, hNCs, and chondrogenic cell line
after 7 days in expansion; magniﬁcation 20× with 100 μm
scale bar. (B) Calcein AM staining of hASCs, hNCs, and
ATDC5 encapsulated in κC hydrogels on day 7 of culture;
magniﬁcation 20× with 100 μm scale bar.
of all cells encapsulated in the hydrogels, whereas hASCs de-
picted a tendency to form cell clusters.
4.3. Metabolic activity and proliferation of
encapsulated cells
Viability of encapsulated cells within κC hydrogels during
3 weeks of culture was assessed using the MTS assay. In gen-
eral, a decreased viability was observed over time for all types
of cells encapsulated in κC hydrogels (Fig. 3A), as it is typically
observed in cells encapsulated in hydrogels [38–40]. This drop
in cell proliferation could be due to, at least partially, the fact
that cells are being released from the hydrogel systems during
culturing, owing to degradation of the hydrogels. Furthermore,
studies report that ions needed for hydrogel formation may
inﬂuence the cell viability/proliferation and that low concentra-
tionhashigher cell viability [41],[42]. Thus, remainingpotassium
ions could have also contributed to the decrease in cell viabil-
ity. The effect of hydrogel concentration and thus its stiffness
is also thought to affect encapsulated cells because the inverse
dependency between permeability and stiffness is known [43].
The data obtained also demonstrated that hASCs and nasal
Fig. 3. (A) Metabolic activity results based on MTS test
performed on 0, 7, 14, and 21 days of culture. (B) Cell
content obtained from by DNA quantiﬁcation of hASCs,
hNCs, and ATDC5 encapsulated in κC hydrogels and
cultured for 21 days in speciﬁc mediums. Error bars
represent means ± SD (n = 9). The statistics using
one-way ANOVA indicate that the mean difference is
signiﬁcant at the 0.05 level (P < 0.05). The symbol ∗
indicates statistical signiﬁcance between hASCs or hNCs
and ATDC5 cell type in terms of metabolic activity response,
and # implies statistical signiﬁcance on day 14 and 21
between hASCs and hNCs or ATDC5 in the proliferation rate.
chondrocytes, once encapsulated within the biodegradable hy-
drogel, are more metabolically active than ATDC5 cells (P <
0.05). DNA quantiﬁcation (Fig. 3B) shows that hASCs encapsu-
lated in κC hydrogels exhibit higher cell content than hydro-
gels laden with hNCs and ATDC5. This difference was found
to be statistically signiﬁcant (P < 0.05) at 14 and 21 days of
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Fig. 4. Optical microscopic images of histological sections obtained from κC hydrogels with encapsulated cells, collected after
21 days of culture and stained with Alcian blue and Safranin O. The scale bar corresponds to 100 μm and the magniﬁcation
used was 20× . Embedded pictures correspond to light microscopy images of stained hASCs, hNCs, and ATDC5 cell
monolayers after culturing for 3 weeks.
culture. There are several hypotheses for the observed differ-
ences among the cells used. Each cell type was incubated in a
differentmedium; therefore, we cannot rule out the effect of the
cell culture medium and added supplements. This is probably
related to the different growth proﬁle of the different cells ana-
lyzed. Cell metabolic activity and proliferation data clearly indi-
cate that κC, an easy-to-handle, simple, and nontoxic hydrogel
formed under mild conditions with in situ gelation properties,
sustains cell growth and proliferation for a long time in culture
using different cell types.
4.4. GAG deposition
The GAG deposition in the hydrogels laden with the different
cell types was evaluated by histological staining. Light micro-
scopic images of sample sections obtained from hydrogels with
encapsulatedhASCs, hNCs, or ATDC5 cells stainedwithSafranin
O and Alcian blue revealed positive staining for both cartilage
ECM markers, conﬁrming the extracellular matrix secretion by
all the cell types embedded in the κC hydrogel, after 3 weeks of
culture (Fig. 4). It is known that the extracellular matrix is not a
static structure, but a dynamic network of molecules secreted
by cells [44],[45], and thus the staining indicated a progressive
increase in intensity over the period of culture (data not pre-
sented). The cell concentration chosen for the cell experiments
was 5 × 106 cells/mL, based on previous studies [46], [47] and
was the same for all the cell types investigated, to allow a more
straightforward comparison among the outcomes produced by
the different cell types [48]. Nevertheless, cell density has an
important role in extracellular formation and may affect differ-
ently the different cell types used herein. It was noteworthy
that the distribution of the cartilagematrix in the hydrogels was
homogeneous for all cell types. Furthermore, ASCs exhibited
stronger staining intensity, clearly demonstrating the chondro-
genic differentiation undergone by these cells embedded in κC
and stimulated by the chondrogenic supplements in the culture
media. The round-shape cell morphology observed is a further
indication of chondrocyte phenotype achieved by hASCs [49].
These results show that the κC hydrogel is not only acting as
a cell vehicle but is also supporting cell functionality—namely,
the chondrogenic differentiation—suggesting that thismaterial
can actually mimic ECM properties to a certain range, rendering
it attractive for cartilage regeneration strategies.
4.5. Real-time qRT-PCR
The results obtained from the genotypic quantiﬁcation of
cartilage-related genes for hASCs, hNCs, and ATDC5 after 7,
14, and 21 days of culture within κC hydrogels are presented in
Fig. 5. The relativeexpressionof thecartilage-speciﬁcgeneswas
normalized against the housekeeping gene GAPDH and com-
pared with the initial culture time. A constitutive expression of
allmRNA transcripts [i.e., SOX9, aggrecan (AGCR), collagen type
I (COL1), COL2 (COL2), and collagen type X (COLX)] was found
during the 21 days of culture. In general, hASCs encapsulated
in κC showed higher levels of all markers analyzed, except col-
lagen X, as compared with hNCs and ATDC5 cells. Speciﬁcally,
themRNA levels in hASC cells for day 21 in culture were found to
be upregulated for the following molecules: SOX9 (39.72-fold;
P < 0.05), AGCR (53.57-fold; P < 0.05), type I collagen (10.35-
fold; P < 0.05), type II collagen (94.23-fold; P < 0.05), and
type X collagen (5.7-fold; P < 0.05). SOX9 followed a particular
high expression pattern, increasing until the last day (Fig. 5A).
It has been demonstrated that a highly expressed SOX9 stimu-
lates the production of AGCR and COL2 [50]. In fact, the results
obtained from statistical analysis of the AGCR expression by
hASCs showeda signiﬁcant increase (P<0.05; Fig. 5B) between
14 and 21 days of culture. Along with aggrecan [51], COL2 is a
major structural component of cartilage, particularly articular
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Fig. 5. Real-time analysis of chondrogenic-speciﬁc gene expressions—namely, (A) SOX9, (B) aggrecan, (C) collagen type I,
(D) COL2, and (E) collagen type X—based on the mRNA produced by the encapsulated cells after 7, 14, and 21 days of culture.
The expression of these genes was normalized against the housekeeping gene GAPDH and calculated by the Livak method.
Error bars represent means ± SD. Statistical analyses were conducted using one-way ANOVA for n = 3; P < 0.05.
cartilage [52]. COL2 is the most important protein produced by
chondrocytes, and the tensile property of cartilage depends on
that,whereas aggrecan is responsible for the compressive prop-
erties [53]. The expression of the COL2 transcript was detected
for all time points, with low values for day 14 and a signiﬁcant
increase for day 21 (P < 0.05; Fig. 5D). Even if COL2 exhibits
a decreased expression on day 14, aggrecan gene expression
has an increase, as these chondrogenic markers interplaying
together are being expressed differently during chondrogenic
differentiation. In contrast, for hASCs, collagen type I expres-
sion showed no signiﬁcant increases between day 14 and 21 of
culture (Fig. 5C), suggesting that an elastic cartilage-like tissue
was formed (characterized by high expression of COL2) instead
of ﬁbrocartilage, usually characterized by the expression of col-
lagen type I. In this system, hASCs were likely stimulated down
the chondrogenic pathway by TGF-β1 growth factor present in
the chondrogenic medium [54]. A signiﬁcant increase in the
mRNA levels of COL2 gene was registered for hNCs during the
21 days of culture (P < 0.05), although at lower levels as com-
paredwith the increase in expression for the stemcells (Fig. 5D).
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The ATDC5 cells showed a high expression for COL2 gene and a
low upregulation for AGCR on day 14, but no signiﬁcant levels of
the remaining genes analyzed were recorded (Figs. 5D and 5B).
Interactions with κC matrix may have subsequently guided cell
behavior favoring chondrogenic induction, thus explaining the
regulation in COL2 gene expression among different cell types,
as suggested by other work [55]. Collagen type X is expressed in
identical level values for all types of cultures and all time points
(Fig. 5E). All cell types show an increased expression marker
of this gene, frequently associated with the dedifferentiation of
chondrocytes, suggesting that increasing theculturing timemay
compromise the functionality of these cells [56],[57]. ATDC5 cul-
ture produces chondrocyte maturation and apoptosis, indicat-
ing that this cell line is also suitable to study in vitro the miner-
alization process [58]. In summary, the data gathered from real-
time RT-PCR analysis demonstrated that hASCs and nasal chon-
drocytes lead to better results in terms of chondrogenic poten-
tial when compared with ATDC5 cells. Moreover, hASCs showed
higher phenotypic and functional characteristics against hNCs,
demonstrating that these cells could be an alternative to the
autologous approach already used in clinical applications. The
obtained results also indicate thatκChydrogels are able to stim-
ulate speciﬁc cellular responses at the molecular level when
the encapsulated cells present a different growth proﬁle with
respect to early and late cellular events in the growth proﬁle
of cells.
5. Conclusion
TheκCsystemenabled the viability andproliferationof different
cells during long-term cell culture and showed its efﬁciency to
support the production of an organized extracellular matrix and
other chondrogenic features, as well as its ability to support the
chondrogenic differentiation of human adipose stem cells. In
fact, hASCs showed a better cellular response when encapsu-
lated in κC hydrogels than primary chondrocytes obtained from
nasal septum cartilage. Taking into account these ﬁndings, to-
gether with their wider availability and easier harvesting, it is
possible to conclude that hASCs could serve as an alternative
cell source to chondrocyte transplantation therapy. Altogether,
the results obtained from this study clearly indicate the great
potential for the application of κC laden with hASCs in cartilage
regeneration.
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